Participated · Series B · Sep 2025

Mercy BioAnalytics develops extracellular vesicle–based liquid biopsy tests aimed at the early detection of cancer. Its patented Mercy Halo platform uses biomarker co-localization to interrogate abundant blood-based extracellular vesicles that carry cancer signatures from their cell of origin. The company’s initial focus is the early detection of ovarian and lung cancers, and its blood-based ovarian cancer test portfolio is designed to detect pre-clinical high grade serous ovarian carcinoma in post-menopausal women. Mercy says the Mercy Halo ovarian cancer screening test shows unprecedented sensitivity and specificity in a blinded evaluation of samples from a randomized controlled trial. The company plans to commercialize its ovarian cancer tests and expand the Mercy Halo portfolio to include multi-cancer and lung cancer screening tests. Mercy is based in Waltham, Mass., and recently closed a financing to support commercialization and portfolio expansion. Mercy BioAnalytics is advancing the Mercy Halo extracellular vesicle‑based liquid biopsy platform to enable early detection of cancer. Mercy Halo seeks high clinical sensitivity and specificity by simultaneously detecting multiple cancer‑related biomarkers co‑localized on individual tumor‑derived extracellular vesicles. The test can be run on a very small volume of serum or plasma and uses a simple PCR‑based readout. The company closed an oversubscribed $41 million Series A to advance development and commercialization, with an initial focus on high‑risk lung cancer screening. Proceeds will also support clinical programs in ovarian cancer and the development of a broader portfolio of early‑detection tests. Preliminary data presented at ASCO, AACR and EDCC demonstrated promising performance for detecting Stage I and II lung and ovarian cancers, and Mercy is planning larger independent validation studies.

Participated · Seed · Oct 2023

MDisrupt is an Austin, TX–based marketplace serving the health tech and life sciences industries. Its AI-powered Health Expert Marketplace connects companies with over 2,500 professionals, including clinicians, health system executives, and payor leaders. The platform streamlines access to essential expertise to enable rapid product development and validation. The company raised $1M in funding led by American Heart Association Ventures, and Lisa Suennen joined the MDisrupt board. MDisrupt says it will use the funds to support expanded adoption of its AI-powered marketplace and to add new features through a strategic collaboration with the Association to meet members' needs. The company is led by CEO and founder Ruby Gadelrab. MDisrupt is a marketplace that connects healthtech and life science companies with health experts to help build, commercialize and scale health products. Led by founder and CEO Ruby Gadelrab and based in Austin, TX, the company reports a network of over 1,500 experts from organizations including Blue Cross Blue Shield, CVS, Willis Towers Watson, the U.S. FDA, Optum, and Cleveland Clinic. MDisrupt serves both startups and enterprise customers across healthtech and life science sectors. The company raised $3M in Seed funding and intends to use the capital to launch its platform and expand its client roster. In conjunction with the round, Cat Middleton of The Venture Collective is joining the MDisrupt board of directors. MDisrupt is transforming into a digital health intelligence company that organizes the world's digital health products by performance through clinically crowdsourced data generation. Founded in 2019 and based in Austin, Texas, it connects digital health companies with health industry experts and has helped more than 55 companies build and scale products. The company's platform combines three elements—people, platform, and data—to digitize solutions for access to experts on demand, clinical early adopters, and real-world performance data. MDisrupt plans to expand the platform to enable innovators to rapidly generate the real-world performance data needed to commercialize and scale their products and to serve as a marketplace and benchmark for the industry. The platform's objective dataset, built on real-world clinical performance from every digital health product on the platform, will feed its digital health intelligence engine. The company says the output will influence key decision-makers and provide standards and benchmarks for the growing digital health sector.

Participated · Seed · May 2022

Wellbees offers an enterprise-focused, AI-powered employee wellbeing platform operating in more than 100 countries and supporting 38 languages. The platform covers physical, mental, emotional, social, financial, occupational, environmental, intellectual, and spiritual wellbeing through services such as expert consultations, habit tracking, wellness programs, employee engagement initiatives, analytics, and next-generation Employee Assistance Programs (EAPs). Wellbees emphasizes personalized and measurable wellbeing experiences for organizations. Following its $3.6 million Series A, the company is planning expansion across the Gulf, including opening a Qatar office and growing a regional team. Wellbees will also invest in software and product development and enhance its AI capabilities with the new funding. The company has attracted both institutional and angel participation, including existing investor Sabancı Ventures.

Participated · Equity · Mar 2022

Rebel Girls is a global multi‑media brand focused on empowerment storytelling for girls across books, audio, a mobile app, consumer products and events. The brand began innovating in children’s media in 2016 with Good Night Stories for Rebel Girls, which was the most successful publishing Kickstarter in the platform’s history. Building on its international bestselling book series and a newly launched mobile app, Rebel Girls has a current reach spanning 49 languages and more than 100 countries. Future plans include building immersive online/offline experiences, accelerating translations (including Arabic), and rolling out localized editions and regional partnerships in the MENA region. The company reports a community of more than 20 million self‑identified Rebel Girls, has sold 7.5 million books and reached 17 million audio listens. The recent fundraising is intended to support scaling the brand’s ecosystem and reaching millions more girls.

Participated · Seed · Nov 2021

Rosy is a Dallas, TX-based digital wellness platform for women that provides access to services and benefits focused on sexual health, plus educational resources including videos and self-help materials. Founded in 2018, the company operates as a SaaS product with a freemium option (7-day trial) and premium monthly or six-month subscription plans. In two years Rosy has assembled a network of roughly 3,400 doctors and therapists and 1,900 OB/GYNs, representing about 6% of U.S. professionals in that specialty. The company plans to use new funding to hire business staff, a CTO, engineers and designers and to accelerate product development, including launching a digital cognitive behavioural therapy (CBT) programme. Rosy also intends to grow referrals to over 5,500 professionals and expand marketing to reach a user base of 1 million via social campaigns, affiliate marketing, events and strategic partnerships. Financially, Rosy completed a seed fundraising to support these growth and product initiatives. Rosy is an evidence-based technology platform that provides education and resources for women with low sexual desire. Its app features a sexual wellness score, an extensive library of educational videos, erotic stories, guided classes, and a community for open discussion. The platform reports more than 2,500 healthcare providers and physicians actively referring patients to Rosy. Its education and resource library includes more than 100 unique, short video lessons, guided classes, and romantic stories. Rosy recently launched an anonymous community where women can ask questions about sex and relationships. The company is led by Founder and CEO Dr. Lyndsey Harper, MD, and recently raised seed funding to support its growth.